Kunal S. Taskar

2.1k citations

30 papers · 1.4k indexed · 1 hit paper · h-index 15

Impact in

Oncology top 5%
- Drug Transport and Resistance Mechanisms
- Lung Cancer Research Studies
Pharmacology top 2%
- Pharmacogenetics and Drug Metabolism

Papers in ⓘ

Pharmacology 10
- Pharmacogenetics and Drug Metabolism 9
Pediatrics, Perinatology and Child Health 18
- Pharmacological Effects and Toxicity Studies 17

Co-authors: Helen R. Thorsheim (4 shared papers)Quentin R. Smith (4 shared papers)Patricia S. Steeg (4 shared papers)Diane Palmieri (3 shared papers)Rajendar K. Mittapalli (3 shared papers)Paul R. Lockman (3 shared papers)Vinay Rudraraju (3 shared papers)Julie A. Gaasch (2 shared papers)
Journals: Clinical Pharmacology & Therapeutics (9 papers)CPT Pharmacometrics & Systems Pharmacology (4 papers)Drug Metabolism and Disposition (4 papers)Pharmaceutical Research (3 papers)Molecular Pharmaceutics (2 papers)
Partner nations: United Kingdom United States Japan

In The Last Decade

Kunal S. Taskar

29 papers receiving 1.4k citations

Hit Papers

align trajectories log scale

Heterogeneous Blood–Tumor Barrier Permeability Determines Drug Efficacy in Experimental Brain Metastases of Breast Cancer 2010 · 524 citations

Peers

Countries citing papers authored by Kunal S. Taskar

Since Specialization

Citations

This map shows the geographic impact of Kunal S. Taskar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kunal S. Taskar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kunal S. Taskar more than expected).

Fields of papers citing papers by Kunal S. Taskar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kunal S. Taskar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kunal S. Taskar. The network helps show where Kunal S. Taskar may publish in the future.

Co-authors

The 25 scholars most cited alongside Kunal S. Taskar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Kunal S. Taskar Line = papers co-authored together Kunal S. Taskar links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Heterogeneous Blood–Tumor Barrier Permeability Determines Drug Efficacy in Experimental Brain Metastases of Breast Cancer Clinical Cancer Research ·Paul R. Lockman, Rajendar K. Mittapalli, Kunal S. Taskar, Vinay Rudraraju, Brunilde Gril, Kaci A. Bohn, Chris E. Adkins, Amanda Roberts, Helen R. Thorsheim, Julie A. Gaasch, Suyun Huang, Diane Palmieri, Patricia S. Steeg, Quentin R. Smith Hit paper breakdown →	2010	524
2	Uptake of ANG1005, A Novel Paclitaxel Derivative, Through the Blood-Brain Barrier into Brain and Experimental Brain Metastases of Breast Cancer Pharmaceutical Research ·Fancy Thomas, Kunal S. Taskar, Vinay Rudraraju, Satyanarayana Goda, Helen R. Thorsheim, Julie A. Gaasch, Rajendar K. Mittapalli, Diane Palmieri, Patricia S. Steeg, Paul R. Lockman, Quentin R. Smith	2009	173
3	Lapatinib Distribution in HER2 Overexpressing Experimental Brain Metastases of Breast Cancer Pharmaceutical Research ·Kunal S. Taskar, Vinay Rudraraju, Rajendar K. Mittapalli, Ramakrishna Samala, Helen R. Thorsheim, Julie A. Lockman, Brunilde Gril, Emily Hua, Diane Palmieri, Joseph W. Polli, Stephen Castellino, Stephen D. Rubin, Paul R. Lockman, Patricia S. Steeg, Quentin R. Smith	2011	160
4	Physiologically‐Based Pharmacokinetic Models for Evaluating Membrane Transporter Mediated Drug–Drug Interactions: Current Capabilities, Case Studies, Future Opportunities, and Recommendations Clinical Pharmacology & Therapeutics ·Kunal S. Taskar, Venkatesh Pilla Reddy, Howard Burt, Maria M. Posada, Manthena V. S. Varma, Ming Zheng, Mohammed Ullah, Arian Emami Riedmaier, Kenichi Umehara, Jan Snoeys, Masanori Nakakariya, Xiaoyan Chu, Maud Bénéton, Yuan Chen, Felix Huth, Rangaraj Narayanan, Dwaipayan Mukherjee, Vaishali Dixit, Yuichi Sugiyama, Sibylle Neuhoff	2019	110
5	Importance of Hepatic Transporters in Clinical Disposition of Drugs and Their Metabolites The Journal of Clinical Pharmacology ·Mitesh Patel, Kunal S. Taskar, Maciej J. Zamek‐Gliszczynski	2016	81
6	Can Bile Salt Export Pump Inhibition Testing in Drug Discovery and Development Reduce Liver Injury Risk? An International Transporter Consortium Perspective Clinical Pharmacology & Therapeutics ·J. Gerry Kenna, Kunal S. Taskar, Christina Battista, David L. Bourdet, Kim L. R. Brouwer, Kenneth R. Brouwer, David L. Dai, Christoph Funk, Michael J. Hafey, Yurong Lai, Jonathan Maher, Y. Anne Pak, Jenny M. Pedersen, Joseph W. Polli, A. David Rodrigues, Paul B. Watkins, Kyunghee Yang, Robert W. Yucha	2018	80
7	Intestinal P‐gp and Putative Hepatic OATP1B Induction: International Transporter Consortium Perspective on Drug Development Implications Clinical Pharmacology & Therapeutics ·Maciej J. Zamek‐Gliszczynski, Mitesh Patel, Xinning Yang, Justin D. Lutz, Xiaoyan Chu, Kim L. R. Brouwer, Yurong Lai, Caroline A. Lee, Sibylle Neuhoff, Mary F. Paine, Yuichi Sugiyama, Kunal S. Taskar, Aleksandra Galetin	2020	39
8	Clinical Implications of Altered Drug Transporter Abundance/Function and PBPK Modeling in Specific Populations: An ITC Perspective Clinical Pharmacology & Therapeutics ·Xiaoyan Chu, Bhagwat Prasad, Sibylle Neuhoff, Kenta Yoshida, J. Steven Leeder, Dwaipayan Mukherjee, Kunal S. Taskar, Manthena V. S. Varma, Xinyuan Zhang, Xinning Yang, Aleksandra Galetin	2022	38
9	Effect of Cyclosporin A and Impact of Dose Staggering on OATP1B1/1B3 Endogenous Substrates and Drug Probes for Assessing Clinical Drug Interactions Clinical Pharmacology & Therapeutics ·Tatsuki Mochizuki, Maciej J. Zamek‐Gliszczynski, Kenta Yoshida, Jialin Mao, Kunal S. Taskar, Hideki Hirabayashi, Xiaoyan Chu, Yurong Lai, Tadayuki Takashima, Kevin Rockich, Yoshiyuki Yamaura, Kaku Fujiwara, Tadahaya Mizuno, Kazuya Maeda, Kenichi Furihata, Yuichi Sugiyama, Hiroyuki Kusuhara	2022	27
10	Physiologically‐based pharmacokinetic model‐based translation of OATP1B‐mediated drug–drug interactions from coproporphyrin I to probe drugs Clinical and Translational Science ·Tatsuki Mochizuki, Yasunori Aoki, Takashi Yoshikado, Kenta Yoshida, Yurong Lai, Hideki Hirabayashi, Yoshiyuki Yamaura, Kevin Rockich, Kunal S. Taskar, Tadayuki Takashima, Xiaoyan Chu, Maciej J. Zamek‐Gliszczynski, Jialin Mao, Kazuya Maeda, Kenichi Furihata, Yuichi Sugiyama, Hiroyuki Kusuhara	2022	24
11	Clinical Relevance of Hepatic and Renal P‐gp/BCRP Inhibition of Drugs: An International Transporter Consortium Perspective Clinical Pharmacology & Therapeutics ·Kunal S. Taskar, Xinning Yang, Sibylle Neuhoff, Mitesh Patel, Kenta Yoshida, Mary F. Paine, Kim L. R. Brouwer, Xiaoyan Chu, Yuichi Sugiyama, Jack Cook, Joseph W. Polli, Imad Hanna, Yurong Lai, Maciej J. Zamek‐Gliszczynski, (unknown)	2022	23
12	Vinorelbine Delivery and Efficacy in the MDA-MB-231BR Preclinical Model of Brain Metastases of Breast Cancer Pharmaceutical Research ·Ramakrishna Samala, Helen R. Thorsheim, Satyanarayana Goda, Kunal S. Taskar, Brunilde Gril, Patricia S. Steeg, Quentin R. Smith	2016	23
13	Clinical Extrapolation of the Effects of Dolutegravir and Other HIV Integrase Inhibitors on Folate Transport Pathways Drug Metabolism and Disposition ·Maciej J. Zamek‐Gliszczynski, Xuexiang Zhang, Jennypher Mudunuru, Yewei Du, Jian-Lu Chen, Kunal S. Taskar, Jane Huang, Yong Huang, Elizabeth H. Romach	2019	17
14	Physiologically-based Pharmacokinetic (PBPK) Modelling of Transporter Mediated Drug Absorption, Clearance and Drug-drug Interactions Current Drug Metabolism ·Kunal S. Taskar, Isobel Harada, Ravindra V. Alluri	2021	16
15	Industrial Perspective on the Benefits Realized From the FDA’s Model‐Informed Drug Development Paired Meeting Pilot Program Clinical Pharmacology & Therapeutics ·Gerald R. Galluppi, Satjit Brar, Luzelena Caro, Yuan Chen, Nicolas Frey, Hans Peter Grimm, Deanne Jackson Rudd, Chi‐Chung Li, Mindy Magee, Arnab Mukherjee, Lee M. Nagao, Vivek S. Purohit, Amit Roy, Ahmed Hamed Salem, Vikram Sinha, Ahmed A. Suleiman, Kunal S. Taskar, Vijay Upreti, Benjamin Weber, Jack Cook	2021	16
16	Robust physiologically based pharmacokinetic model of rifampicin for predicting drug–drug interactions via P‐glycoprotein induction and inhibition in the intestine, liver, and kidney CPT Pharmacometrics & Systems Pharmacology ·Ryuta Asaumi, Ken‐ichi Nunoya, Yoshiyuki Yamaura, Kunal S. Taskar, Yuichi Sugiyama	2022	14
17	When special populations intersect with drug–drug interactions: Application of physiologically‐based pharmacokinetic modeling in pregnant populations Biopharmaceutics & Drug Disposition ·Caroline Sychterz, Aleksandra Galetin, Kunal S. Taskar	2021	14
18	Estimation of the Unbound Brain Concentration of P-Glycoprotein Substrates or Nonsubstrates by a Serial Cerebrospinal Fluid Sampling Technique in Rats Molecular Pharmaceutics ·T. Thanga Mariappan, Vishwanath Kurawattimath, Shashyendra Singh Gautam, Chetan P. Kulkarni, Rajareddy Kallem, Kunal S. Taskar, Punit H. Marathe, Sandhya Mandlekar	2013	10
19	Effects of Cimetidine and Dolutegravir on the Endogenous Drug–Drug Interaction Biomarkers for Organic Cation Transporter 2 and Multidrug and Toxin Extrusion Protein 1 in Healthy Volunteers Clinical Pharmacology & Therapeutics ·Tomoki Koishikawa, Kaku Fujiwara, Kunal S. Taskar, Maciej J. Zamek‐Gliszczynski, Kenta Yoshida, Xiaoyan Chu, Hideaki Hirabayashi, Jialin Mao, Kevin Rockich, Tadayuki Takashima, Yoshiyuki Yamaura, Yurong Lai, Yukana Tomoda, Tomoko Kito, Kazuya Maeda, Kenichi Furihata, Yuichi Sugiyama, Hiroyuki Kusuhara	2024	7
20	Unmasking the Role of Uptake Transporters for Digoxin Uptake Across the Barriers of the Central Nervous System in Rat SHILAP Revista de lepidopterología ·Kunal S. Taskar, T. Thanga Mariappan, Vishwanath Kurawattimath, Shashyendra Singh Gautam, TV Radhakrishna Mullapudi, Srikanth Sridhar, Raja Reddy Kallem, Punit Marathe, Sandhya Mandlekar	2017	7

About Kunal S. Taskar

Kunal S. Taskar is a scholar working on Pharmacology, Pediatrics, Perinatology and Child Health, Oncology, Genetics and Infectious Diseases, having authored 30 papers that have together received 1.4k indexed citations. Recurring topics across this work include Pharmacological Effects and Toxicity Studies (17 papers), Drug Transport and Resistance Mechanisms (17 papers), Pharmacogenetics and Drug Metabolism (9 papers), Pregnancy and Medication Impact (5 papers), HIV/AIDS drug development and treatment (5 papers), Brain Metastases and Treatment (4 papers), Glioma Diagnosis and Treatment (3 papers) and Lung Cancer Research Studies (2 papers). The work is most often cited by research in Oncology (790 citations), Pharmacology (236 citations), Genetics (280 citations), Pulmonary and Respiratory Medicine (462 citations) and Neurology (114 citations). Kunal S. Taskar has collaborated with scholars based in United Kingdom, United States and Japan. Frequent co-authors include Helen R. Thorsheim, Quentin R. Smith, Patricia S. Steeg, Diane Palmieri, Rajendar K. Mittapalli, Paul R. Lockman, Vinay Rudraraju, Julie A. Gaasch, Brunilde Gril and Maciej J. Zamek‐Gliszczynski. Their work appears in journals such as Clinical Pharmacology & Therapeutics, CPT Pharmacometrics & Systems Pharmacology, Drug Metabolism and Disposition, Pharmaceutical Research and Molecular Pharmaceutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact